Journal article
Interplay between cannabinoids and the neuroimmune system in migraine
Journal of headache and pain, Vol.25(1), 178
10/16/2024
DOI: 10.1186/s10194-024-01883-3
PMCID: PMC11481476
PMID: 39407099
Abstract
Migraine is a common and complex neurological disorder that has a high impact on quality of life. Recent advances with drugs that target the neuropeptide calcitonin gene-related peptide (CGRP) have helped, but treatment options remain insufficient. CGRP is released from trigeminal sensory fibers and contributes to peripheral sensitization, perhaps in part due to actions on immune cells in the trigeminovascular system. In this review, we will discuss the potential of cannabinoid targeting of immune cells as an innovative therapeutic target for migraine treatment. We will cover endogenous endocannabinoids, plant-derived phytocannabinoids and synthetically derived cannabinoids. The focus will be on six types of immune cells known to express multiple cannabinoid receptors: macrophages, monocytes, mast cells, dendritic cells, B cells, and T cells. These cells also contain receptors for CGRP and as such, cannabinoids might potentially modulate the efficacy of current CGRP-targeting drugs. Unfortunately, to date most studies on cannabinoids and immune cells have relied on cell cultures and only a single preclinical study has tested cannabinoid actions on immune cells in a migraine model. Encouragingly, in that study a synthetically created stable chiral analog of an endocannabinoid reduced meningeal mast cell degranulation. Likewise, clinical trials evaluating the safety and efficacy of cannabinoid-based therapies for migraine patients have been limited but are encouraging. Thus, the field is at its infancy and there are significant gaps in our understanding of the impact of cannabinoids on immune cells in migraine. Future research exploring the interactions between cannabinoids and immune cells could lead to more targeted and effective migraine treatments.
Details
- Title: Subtitle
- Interplay between cannabinoids and the neuroimmune system in migraine
- Creators
- Erik Zorrilla - University of IowaAdriana Della Pietra - University of IowaAndrew F Russo - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of headache and pain, Vol.25(1), 178
- DOI
- 10.1186/s10194-024-01883-3
- PMID
- 39407099
- PMCID
- PMC11481476
- NLM abbreviation
- J Headache Pain
- ISSN
- 1129-2377
- eISSN
- 1129-2377
- Publisher
- BMC
- Grant note
- NS075599 / NIH HHS VA-ORD I50 RX003002 / U.S. Department of Veterans Affairs
- Language
- English
- Date published
- 10/16/2024
- Academic Unit
- Neurology; Molecular Physiology and Biophysics; Iowa Neuroscience Institute; Craniofacial Anomalies Research Center
- Record Identifier
- 9984736597902771
Metrics
6 Record Views